Total Payments
$96,617
2024 Payments
$71,662
Companies
10
Transactions
96
Medicare Patients
848
Medicare Billing
$91,464
Payment Breakdown by Category
Other$81,537 (84.4%)
Travel$8,240 (8.5%)
Consulting$4,728 (4.9%)
Food & Beverage$2,111 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $81,537 | 25 | 84.4% |
| Travel and Lodging | $8,240 | 24 | 8.5% |
| Consulting Fee | $4,728 | 2 | 4.9% |
| Food and Beverage | $2,111 | 45 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $75,163 | 51 | $0 (2024) |
| GENZYME CORPORATION | $10,856 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $10,237 | 19 | $0 (2024) |
| Mylan Specialty L.P. | $113.29 | 1 | $0 (2019) |
| Electromed, Inc. | $108.96 | 10 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $36.57 | 2 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $36.47 | 1 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $28.12 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $24.13 | 1 | $0 (2019) |
| Theravance Biopharma, Inc. | $13.52 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $71,662 | 39 | Regeneron Healthcare Solutions, Inc. ($66,852) |
| 2023 | $6,046 | 11 | Regeneron Healthcare Solutions, Inc. ($5,884) |
| 2022 | $453.80 | 5 | Regeneron Healthcare Solutions, Inc. ($432.91) |
| 2020 | $6,536 | 6 | GENZYME CORPORATION ($6,057) |
| 2019 | $1,856 | 13 | Regeneron Healthcare Solutions, Inc. ($1,551) |
| 2018 | $88.75 | 6 | GENZYME CORPORATION ($41.03) |
| 2017 | $9,974 | 16 | AstraZeneca Pharmaceuticals LP ($9,974) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,593.00 | General |
| Category: Immunology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $116.31 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,088.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,449.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,438.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $166.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $160.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $390.03 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $299.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $117.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,088.00 | General |
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $368.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $76.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $58.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $100.46 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,020.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,758.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $685.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $620.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $314.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $459.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 266 | 329 | $116,696 | $19,581 |
| 2022 | 7 | 374 | 438 | $123,506 | $21,300 |
| 2021 | 6 | 127 | 223 | $134,408 | $25,204 |
| 2020 | 3 | 81 | 182 | $116,595 | $25,379 |
Total Patients
848
Total Services
1,172
Medicare Billing
$91,464
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 31 | 75 | $77,649 | $13,175 | 17.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 61 | $30,622 | $4,843 | 15.8% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 33 | 33 | $1,617 | $315.86 | 19.5% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 30 | 30 | $1,470 | $297.60 | 20.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 35 | 35 | $1,295 | $247.42 | 19.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 30 | 30 | $1,125 | $219.90 | 19.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 19 | 19 | $646.00 | $128.63 | 19.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 15 | 15 | $882.00 | $127.35 | 14.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 15 | 15 | $846.00 | $118.86 | 14.0% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 16 | 16 | $544.00 | $108.32 | 19.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 34 | 81 | $83,236 | $14,465 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 54 | $26,292 | $4,102 | 15.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 51 | 51 | $2,485 | $488.48 | 19.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 41 | 41 | $2,009 | $404.27 | 20.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 52 | 52 | $1,820 | $368.80 | 20.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 16 | 16 | $1,360 | $294.40 | 21.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 40 | 40 | $1,400 | $291.79 | 20.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 27 | 27 | $1,403 | $222.44 | 15.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2022 | 13 | 13 | $1,105 | $221.94 | 20.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 28 | 28 | $946.00 | $183.07 | 19.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 22 | 22 | $748.00 | $147.28 | 19.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 13 | 13 | $702.00 | $110.37 | 15.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 36 | 95 | $97,470 | $17,289 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 52 | $22,381 | $4,255 | 19.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 21 | $7,272 | $1,805 | 24.8% |
About Dr. Amir Zeki, MD
Dr. Amir Zeki, MD is a Pulmonary Disease healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134239239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amir Zeki, MD has received a total of $96,617 in payments from pharmaceutical and medical device companies, with $71,662 received in 2024. These payments were reported across 96 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($81,537).
As a Medicare-enrolled provider, Zeki has provided services to 848 Medicare beneficiaries, totaling 1,172 services with total Medicare billing of $91,464. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Sacramento, CA
- Active Since 08/30/2006
- Last Updated 01/21/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1134239239
Products in Payments
- DUPIXENT (Biological) $82,803
- BEVESPI AEROSPHERE (Drug) $9,904
- FASENRA (Biological) $262.83
- Yupelri (Drug) $113.29
- SMARTVEST (Device) $108.96
- DUPIXENT (Drug) $89.74
- XOLAIR (Biological) $28.12
- NUCALA (Biological) $24.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Sacramento
Dr. Chinh Phan, D.o, D.O
Pulmonary Disease — Payments: $365,929
Pulmonary Disease $365,929
Dr. Brooks Kuhn, M.d, M.D
Pulmonary Disease — Payments: $165,983
Pulmonary Disease $165,983
Muhammad Afzal, M.d, M.D
Pulmonary Disease — Payments: $99,668
Pulmonary Disease $99,668
Brian Morrissey, Md, MD
Pulmonary Disease — Payments: $73,965
Pulmonary Disease $73,965
Dr. Eman Albaddawi, M.d, M.D
Pulmonary Disease — Payments: $6,015
Pulmonary Disease $6,015
Alan Yee, M.d, M.D
Pulmonary Disease — Payments: $5,822
Pulmonary Disease $5,822